Vital Conversation Diseases of Drugs Ethics of Prescribing with Fleetwood

The highest level of warning the FDA places on a drug is

Drugs discussed in this presentation alone that contain that highest level of warning include

The mechanism of action, if known, can give the prescriber insight into how the drug may act therapeutically, as well as potential adverse effects that may be caused. Mechanisms of action is well understood before any agent is released into the general marketplace.

Depression is a costly disease on many levels. There are many anti-depressants representing multiple classes on the market. Per the various manufacturers, these agents are indicated for what kind of depression?

There is quite the overlap between the Mayo Clinic’s definition of “stress” and the DSM-V’s criteria for Major Depressive Disorder. The things that really set MDD apart—and were historically treated inside a hospital setting with strict schedules and supervision—are

Anti-depressants are prescribed 400% more now than 30 years ago. They are not controlled substances and they are in the prescriptive scope for many NDs. PCPs, NPs, specialists in and out of the mental health arenas write for these agents multiple times each day. Why are they being discussed in an “Ethics” course?

Biologics are now flooding the marketplace, with patents expiring on the first monoclonal antibodies released for use in auto-immunity and generic equivalents being introduced. These agents act by what mechanism?

The biologics tend to make patients suffering from auto-immune diseases feel significantly better (other than the day of infusion). Why would they be discussed in an “Ethics” course?

What are the bigger, more problematic short-term and long-term adverse effects associated with the majority of the biologics?

Which of the following are “mood stabilizers”?